HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Invasive aspergillosis in the setting of cardiac transplantation.

Abstract
Among patients undergoing heart transplantation, Aspergillus is the opportunistic pathogen with the highest attributable mortality. The median time of onset from transplantation for invasive pulmonary aspergillosis (IPA) was 46 days, but the median time to first positive culture result was 104 days among patients with Aspergillus colonization but no invasive disease. Most patients with IPA presented with fever and cough within the first 90 days of transplantation and with single or multiple pulmonary nodules. None of the heart transplant recipients with either IPA or invasive extrapulmonary aspergillosis (IEPA) had associated neutropenia. Human leukocyte antigen A1 locus was found significantly more frequently among patients colonized with Aspergillus than among patients with IPA (P<.006) or IEPA (P<.001). Even in the absence of neutropenia, IPA should be suspected for heart transplant recipients who have fever and respiratory symptoms within the first 3 months of transplantation, have a positive result of culture of respiratory secretions, and have abnormal radiological findings (particularly nodules).
AuthorsJ G Montoya, S V Chaparro, D Celis, J A Cortés, A N Leung, R C Robbins, D A Stevens
JournalClinical infectious diseases : an official publication of the Infectious Diseases Society of America (Clin Infect Dis) Vol. 37 Suppl 3 Pg. S281-92 (Oct 01 2003) ISSN: 1537-6591 [Electronic] United States
PMID12975755 (Publication Type: Comparative Study, Journal Article)
Topics
  • Adult
  • Aspergillosis (epidemiology, mortality, physiopathology, prevention & control)
  • Aspergillus fumigatus
  • Chemoprevention
  • Female
  • Heart Transplantation (adverse effects)
  • Humans
  • Immunocompromised Host
  • Male
  • Postoperative Complications (epidemiology, mortality, physiopathology, prevention & control)
  • Risk Factors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: